Back

How should ATTR cardiac amyloidosis cardiomyopathy be treated?

27 August 2022 (16:45 - 17:00)
Organised by:
Congress Presentation Part of: Management of cardiac transthyretin amyloidosis with or without aortic stenosis Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

3 More presentations in this session

Presentation thumbnail
What is ATTR cardiac amyloidosis and how is it diagnosed?
Doctor M. Corneli (Buenos Aires, AR)
Slides Video
Presentation thumbnail
How common is ATTR cardiac amyloidosis in aortic stenosis and how does it impact on management?
Doctor T. Treibel (London, GB)
Slides Video
Presentation thumbnail
Management of cardiac transthyretin amyloidosis with or without aortic stenosis – discussion.
Video

Access the full session

Session thumbnail
Management of cardiac transthyretin amyloidosis with or without aortic stenosis
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 16:45 CET
You may be interested in
thumbnail
Congress Session
Cardiac TTR amyloidosis: all you need to know
21 May 2022
thumbnail
Congress Presentation
Stabilisers, silencers, and depleters: how should I use them?
30 August 2025
thumbnail
Congress Session
Setting the bar at survival: clinical decision-making in an evolving ATTR-CM landscape
31 August 2025
thumbnail
Congress Presentation
How (and when) to use specific drugs.
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources